FAWZU MOHAMMADU: Open Payments
NPI 1235345430 · AVON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,153 in 120 payments from 20 companies in 2025. Trend: 2023 $707 · 2024 $1,129 · 2025 $2,153
Food & beverage: $2,153
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 42 | $471 |
| AstraZeneca Pharmaceuticals LP | 16 | $372 |
| Lilly USA, LLC | 13 | $267 |
| Astellas Pharma US Inc | 9 | $184 |
| Novo Nordisk Inc | 6 | $138 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $124 |
| GlaxoSmithKline, LLC. | 4 | $91 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $71 |
| PFIZER INC. | 4 | $71 |
| Amneal Pharmaceuticals LLC | 3 | $69 |
Products named: AIRSUPRA, JARDIANCE, Veozah, UBRELVY, QULIPTA, XIFAXAN, Wegovy, MOUNJARO.
Industry payments across CT — which companies pay providers there.
